课题基金 / 基金详情

The analysis of HIV-protease dimerization mechanism at atomic andmolecular resolution, and the design of novel dimerization inhibition compounds.

The analysis of HIV-protease dimerization mechanism at atomic andmolecular resolution, and the design of novel dimerization inhibition compounds.
在原子和分子分辨率上分析HIV蛋白酶二聚机制,并设计新型二聚抑制化合物。
批准号:
24659484
负责人:
MITSUYA Hiroaki
金额:
$2.41万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Challenging Exploratory Research
财政年份:
2012
资助国家:
日本
项目状态:
已结题
起止时间:
2012 至 --

项目摘要

项目成果

MITSUYA Hiroaki的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Using mass spectrometry and X-ray crystal structure analysis, we attempted toelucidate the dimerization dynamics of HIV -1 protease (PR). Our data showed that darunavir (DR V), anFDA-approved PR inhibitor, binds to both monomers and dimers of PR and blocks HIV -1 replication.We also showed that the introduction of DR V -resistance-associated amino acids into PR prevented DR Vfrom binding to PR monomers and decreased the amount of dimerized PR species. The data should be ofutility in not only examining the PR dimerization dynamics but also designing more potent PR inhibitorsthat hardly permit the emergence of DR V -resistant HIV -1 variants.
期刊论文(18)
专著(0)
科研奖励(0)
会议论文
Development of the first AIDSdrugs: AZT and other dideoxynucleosides.In Human Immunodeficiency Virus ReverseTranscriptase
开发第一个艾滋病药物:AZT 和其他双脱氧核苷。在人类免疫缺陷病毒逆转录酶中
DOI: --
发表时间: 2013
期刊:
影响因子: --
作者: [Yarchoan, R. and Mitsuya, H., A]
通讯作者: A
The binding properties of darunavir to HIV-1 protease monomer subunit.
达芦那韦与 HIV-1 蛋白酶单体亚基的结合特性。
DOI: --
发表时间: 2012
期刊:
影响因子: --
作者: [Hironori Hayashi, Nobutoki Takamune, Manabu Aoki, Yasuhiro Koh, Shogo Misumi & (Hiroaki Mitsuya)]
通讯作者: Shogo Misumi & (Hiroaki Mitsuya)
Balancing antiviralpotency and host toxicity: identifyinga nucleotide inhibitor with an optimalkinetic phenotype for HIV-1 reversetranscriptase.
平衡抗病毒效力和宿主毒性:鉴定具有 HIV-1 逆转录酶最佳动力学表型的核苷酸抑制剂。
DOI: 10.1124/mol.112.078758
发表时间: 2012
期刊: Mol Pharmacol
影响因子: 3.6
作者: [Sohl, C.D., Kasiviswanathan, R., Kim,J., Pradere, U., Schinazi, R.F.,Copeland, W.C., Mitsuya, H., Baba, M.,Anderson, K.S.]
通讯作者: K.S.
DOI: 10.1093/nar/gkr694
发表时间: 2012-01
期刊: Nucleic acids research
影响因子: 14.9
作者: [Ndongwe TP, Adedeji AO, Michailidis E, Ong YT, Hachiya A, Marchand B, Ryan EM, Rai DK, Kirby KA, Whatley AS, Burke DH, Johnson M, Ding S, Zheng YM, Liu SL, Kodama E, Delviks-Frankenberry KA, Pathak VK, Mitsuya H, Parniak MA, Singh K, Sarafianos SG]
通讯作者: Sarafianos SG
12
    Study of mechanism of HIV resistance to integrase strand transfer inhibitors (INSTI) aiming at development of INSTI-resistance-repellant therapeutics
    Elucidation of the mechanism of HIV-1's drug resistance against protease inhibitors using crystal structure and thermodynamic analyses
    • 批准号:
      16K15520
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.16万
    • 财政年份:
      2016
    • 负责人:
      MITSUYA Hiroaki
    • 依托单位:
    The molecular mechanism of HIV-1's drug resistance against protease inhibitors including darunavir and the development of novel resistance-repelling protease inhibitors
    • 批准号:
      26293239
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $10.73万
    • 财政年份:
      2014
    • 负责人:
      MITSUYA Hiroaki
    • 依托单位:
    Structural analysis of HIV integrase multimerization and development of inhibitors of integrase interactions with cellular cofactos
    • 批准号:
      25670467
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.41万
    • 财政年份:
      2013
    • 负责人:
      MITSUYA Hiroaki
    • 依托单位:
    海外基金